SF 1098

  • Minnesota Senate Bill
  • 2019-2020 Regular Session
  • Introduced in Senate Apr 28, 2020
  • Passed Senate Apr 20, 2020
  • Passed House May 09, 2020
  • Signed by Governor May 15, 2020

Prescription Drug Pricing Transparency Act

Abstract

Bill Sponsors (38)

Benson

     
Cosponsor

Olson

     
Cosponsor

Xiong, J.

     
Cosponsor

Votes


Actions


Jul 01, 2020

Senate

Effective date 07/01/20

May 15, 2020

Governor of Minnesota

Governor's action Approval 05/12/2020

Senate

Secretary of State Chapter 78 05/12/2020

May 12, 2020

House

Secretary of State, Filed 05/12/2020

Senate

Presentment date 05/12/2020

Governor of Minnesota

Governor approval 05/12/2020

May 11, 2020

Senate

Returned from House

May 09, 2020

House

Bill was passed

House

Third reading

May 07, 2020

House

House rule 1.21, placed on Calendar for the Day Saturday, May 9, 2020

May 05, 2020

House

Second reading

House

Committee report, to adopt

Apr 28, 2020

House

Received from Senate

House

Senate file first reading, referred to Ways and Means

Apr 20, 2020

Senate

Special Order: Amended

Senate

Third reading Passed

Mar 11, 2020

Senate

Comm report: To pass as amended

Senate

Second reading

Feb 20, 2020

Senate

Comm report: To pass as amended and re-refer to Finance

Mar 27, 2019

Senate

Comm report: To pass as amended and re-refer to Judiciary and Public Safety Finance and Policy

Feb 11, 2019

Senate

Referred to Health and Human Services Finance and Policy

Senate

Introduction and first reading

Bill Text

Bill Text Versions Format
Introduction HTML
1st Engrossment HTML
2nd Engrossment HTML
3rd Engrossment HTML
4th Engrossment HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated nightly from the official website of the Minnesota Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.